Literature DB >> 26051690

Valsartan.

Febry Ardiana1, Gunawan Indrayanto2.   

Abstract

Valsartan is an antihypertensive drug which selectively inhibits angiotensin receptor type II. Generally, valsartan is available as film-coated tablets. This review summarizes thermal analysis, spectroscopy characteristics (UV, IR, MS, and NMR), polymorphism forms, impurities, and related compounds of valsartan. The methods of analysis of valsartan in pharmaceutical dosage forms and in biological fluids using spectrophotometer, CE, TLC, and HPLC methods are discussed in details. Both official and nonofficial methods are described. It is recommended to use LC-MS method for analyzing valsartan in complex matrices such as biological fluids and herbal preparations; in this case, MRM is preferred than SIM method.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Assay; Bioanalysis; Chromatography; Impurities; Polymorphs; Related compound; Spectroscopy; Valsartan

Mesh:

Substances:

Year:  2015        PMID: 26051690     DOI: 10.1016/bs.podrm.2015.01.004

Source DB:  PubMed          Journal:  Profiles Drug Subst Excip Relat Methodol        ISSN: 1871-5125


  3 in total

1.  A multi-analyte LC-MS/MS method for screening and quantification of nitrosamines in sartans.

Authors:  Shu-Han Chang; Ching-Chia Chang; Li-Jing Wang; Wei-Ching Chen; Shu-Yu Fan; Chi-Zong Zang; Ya-Hui Hsu; Mei-Chih Lin; Su-Hsiang Tseng; Der-Yuan Wang
Journal:  J Food Drug Anal       Date:  2020-06-15       Impact factor: 6.157

2.  Protective effect of sacubitril/valsartan in patients with acute myocardial infarction: A meta-analysis.

Authors:  Shanshan Liu; Bi Yin; Bo Wu; Zhixing Fan
Journal:  Exp Ther Med       Date:  2022-04-21       Impact factor: 2.751

3.  Combining Co-Amorphous-Based Spray Drying with Inert Carriers to Achieve Improved Bioavailability and Excellent Downstream Manufacturability.

Authors:  Yingxi Zhang; Yuan Gao; Xiaoxiao Du; Rou Guan; Zhonggui He; Hongzhuo Liu
Journal:  Pharmaceutics       Date:  2020-11-08       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.